CAMP Continuation Study/Phase 2 (CAMPCS/2)

本申请适用于哮喘研究中心参与儿童哮喘的研究 管理方案继续研究/第二阶段(CAMPCS/2)。 我们成功地继续遵循CAMPCS协议，收集高质量的数据，同时提供安全和高效的患者护理。西雅图在CAMP中登记了144名患者，其中127名患者已经在CAMPCS中登记。此外，两名试点患者仍在CAMPCS接受治疗。在完成cAMP过渡的患者中，98%继续留在CAMPCS。西雅图CAMPCS的调查人员和工作人员将继续支持通过CAMPCS/2继续对cAMP患者进行随访。CAMPCS的家属和患者继续致力于这项研究，我们预计他们将通过CAMPCS/2继续参与。 CAMPCS/2的摘要和研究计划包含在华盛顿大学的申请书中 大学(罗伯特·斯特伦克，圆周率)。

This application is for ASTHMA, Inc. Research Center to participate in the Childhood Asthma Management Program Continuation Study/Phase 2 (CAMPCS/2). We have succeeded in continuing to follow the CAMPCS protocol by collecting data of high quality, while providing safe and efficient patient care. Seattle enrolled 144 patients in CAMP and 127 of these patients have enrolled in CAMPCS. In addition, two pilot patients continue in CAMPCS. Of the patients who completed transition in CAMP, 98% continued on in CAMPCS..Seattle CAMPCS investigators and staff will continue to support the continuation of follow up of CAMP patients through CAMPCS/2. The families and patients of CAMPCS continue to be committed to the study and we anticipate their continued involvement through CAMPCS/2. The abstract and research plan for CAMPCS/2 is included in the application from the Washington University (Robert Strunk, PI).